The global vaccine vials market attained a value of USD 22.56 Billion in 2024 . The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 6.70%, to reach USD 43.15 Billion by 2034 .
The increased investment in the research and development of vaccines is also bolstering the market growth for vaccine vials. In April 2023, SK Bioscience, a vaccine development company based in South Korea, announced its plan to invest USD 1.8 billion in its vaccine and contract development and manufacturing organization (CDMO) businesses. They intend for strategic mergers and acquisitions initiatives in the vaccine domain, among others. With half of the investment reserved for vaccine development, the company plans to develop 5 more vaccine pipelines.
The vaccine vials market growth is also driven by the growing awareness among patients about immunization and its benefits. The rising healthcare expenditure to improve patient outcomes is another factor that will aid in the expansion of the market size.
This product will be delivered within 3-5 business days.
Global Vaccine Vials Market Overview
Vaccines help to protect the body from various illnesses, particularly bacterial and viral infectious/non-infectious diseases. They are stored in cylindrical units called vaccine vials. The rise in infectious diseases has fuelled the production of vaccines. In 2023, around 64 infectious diseases were reported to affect individuals spanning across 235 countries. The surge in vaccine production to combat infectious diseases and other medical conditions has led to an increased vaccine vials market demand.The increased investment in the research and development of vaccines is also bolstering the market growth for vaccine vials. In April 2023, SK Bioscience, a vaccine development company based in South Korea, announced its plan to invest USD 1.8 billion in its vaccine and contract development and manufacturing organization (CDMO) businesses. They intend for strategic mergers and acquisitions initiatives in the vaccine domain, among others. With half of the investment reserved for vaccine development, the company plans to develop 5 more vaccine pipelines.
The vaccine vials market growth is also driven by the growing awareness among patients about immunization and its benefits. The rising healthcare expenditure to improve patient outcomes is another factor that will aid in the expansion of the market size.
Global Vaccine Vials Market Segmentation
Vaccine Vials Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:Market Breakup by Type
- Single Dose
- Multiple Dose
Market Breakup by Material
- Glass
- Polymer
Market Breakup by Capacity
- 10 ml
- 20 ml
- 5 ml
- 3ml
- 2ml
Market Breakup by Application
- Preventive Vaccine
- Therapeutics Vaccine
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Vaccine Vials Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Cardinal Health Inc.
- Nipro Corporation
- Thermo Fisher Scientific Inc.
- Zebra Technologies Corporation,
- Schott AG,
- Gerresheimer AG
- Lisaline Lifescience Technologies Pvt Ltd.
- DWK Life Sciences GmbH
- Catalent, Inc.,
- EVIGENCE SENSORS Inc.,
- Richland Glass Company Inc.
- Vetter Pharma
- Pacific Vial Manufacturing Inc.,
- Berlin Material Type LLC
- Stevanato Group
Key Queries Solved in the Global Vaccine Vials Market Report
- How will the market landscape evolve in the coming years?
- What are the key market trends influencing the market?
- What are the major drivers, opportunities, and restraints in the market?
- Which country is poised to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What types of vaccine vials are available in the market?
- Which vaccine vial material is expected to dominate the respective market segment?
- Which key market players are projected to influence the market?
- What are the key research initiatives expected to boost the vaccine vials market share during the forecast period?
- What technological advancements and innovations are influencing vaccine vial design, materials, and manufacturing processes?
- Which segment has the most major impact on the market size?
- How did the COVID-19 pandemic affected the vaccine vials market?
- How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Vaccine Vials Market Overview
4 Global Vaccine Vials Market Landscape*
5 Global Vaccine Vials Market Dynamics
6 Global Vaccine Vials Market Segmentation (2018-2034)
7 North America Sterility testing market (2018-2034)
8 Europe Sterility testing market (2018-2034)
9 Asia Pacific Sterility testing market (2018-2034)
10 Latin America Sterility testing market (2018-2034)
11 Middle East and Africa Sterility testing market (2018-2034)
12 Regulatory Framework
13 Patent Analysis
14 Grants Analysis
15 Funding and Investment Analysis
16 Partnership and Collaborations Analysis
17 Supplier Landscape
Companies Mentioned
- Cardinal Health Inc.
- Nipro Corporation
- Thermo Fisher Scientific Inc.
- Zebra Technologies Corporation,
- Schott AG,
- Gerresheimer AG
- Lisaline Lifescience Technologies Pvt Ltd.
- DWK Life Sciences GmbH
- Catalent, Inc.,
- EVIGENCE SENSORS Inc.,
- Richland Glass Company Inc.
- Vetter Pharma
- Pacific Vial Manufacturing Inc.,
- Berlin Material Type LLC
- Stevanato Group,